Lv314
365 积分 2021-04-26 加入
Tackling the next decade of cancer research
3天前
已完结
PankoMab: a potent new generation anti-tumour MUC1 antibody
6天前
已完结
TA-MUC1 as detected by the fully humanized, therapeutic antibody Gatipotzumab predicts poor prognosis in cervical cancer
7天前
已完结
Preclinical studies of the bispecific MUC1xEGFR antibody drug conjugate M1231 in EGFR mutant NSCLC
8天前
已完结
Effects of Kras activation and Pten deletion alone or in combination on MUC1 biology and epithelial-to-mesenchymal transition in ovarian cancer
8天前
已完结
A Comprehensive Review of Targeting RAF Kinase in Cancer Targeting RAF Kinase in Cancer
8天前
已完结
Unlocking the potential of antibody–drug conjugates for cancer therapy
8天前
已完结
Challenges and Opportunities of Emerging Mechanisms of Resistance to KRASG12C Inhibitors
8天前
已关闭
Targeting N-Myc in neuroblastoma with selective Aurora kinase A degraders
9天前
已完结
The targeted protein degradation landscape
9天前
已完结
皖公网安备34019202002308
